Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'

Trends in Immunology

Volumn 23, Issue 7, 2002, Pages 330-332

  Pawelec, Graham ^a   Ouyang, Qin ^a   Colonna Romano, Giuseppina ^b   Candore, Giuseppina ^b   Lio, Domenico ^b   Caruso, Calogero ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Gruppo di Studio sull'Immunosenescenza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

CONFERENCE PAPER; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HUMAN; IMMUNE SYSTEM; PHENOTYPE; SENESCENCE; T LYMPHOCYTE; VACCINATION;

AGING; HUMANS; IMMUNOPHENOTYPING; ITALY; RISK FACTORS;

EID: 0036644685     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02255-X     Document Type: Conference Paper

References (8)

1. Perspective: Aging and infectious diseases: Past, present, and future
2. T cells and aging. 2002 update
3. Comment: The SENIEUR protocol after 16 years
4. The SENIEUR protocol after 16 years: The next step is to study the interaction of ageing and disease
5. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: The Swedish NONA immune study
6. Aging and proinflammatory cytokines
7. The network and the remodelling theories of aging: Historical background and new perspectives
8. Stress resistance by caloric restriction for longevity